Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 64,681 shares at $76.50 ($4.9M) on 2019-03-14, disclosed to the SEC on 2019-03-14.
Open-market sale of $4.9M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.03 | 1,648 | $125K | 2.5% |
| 2 | $76.50 | 798 | $61K | 1.2% |
| 3 | $76.50 | 891 | $68K | 1.4% |
| 4 | $76.50 | 1,375 | $105K | 2.1% |
| 5 | $76.50 | 7,982 | $611K | 12.3% |
| 6 | $76.50 | 51,987 |
| $4.0M |
| 80.4% |
| Total | $76.49 avg | 64,681 | $4.9M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |